{
    "nct_id": "NCT04992507",
    "official_title": "The Impact of Total Intravenous Anesthesia Following Cancer Surgery (TIVACS) Study",
    "inclusion_criteria": "* Adults: â‰¥18 years old on the day of consent\n* Non-metastatic pancreatic adenocarcinoma\n* Able to provide consent\n* ECOG performance status of 0 or 1\n* Women of childbearing potential (WOCBP) must have a negative urine or serum pregnancy test for the patient at the time of surgery.\n* Ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Previous identified allergy or hypersensitivity to any component of the study treatment\n* Allergies to eggs, egg products, soybeans, or soy products\n* Personal or first degree relative with a history of malignant hyperthermia\n* Has a known additional malignancy that is expected to require active treatment within two years, or is likely to be life-limiting in the opinion of the treating investigator. Superficial bladder cancer, non-melanoma skin cancers, or low-grade prostate cancer not requiring therapy would not exclude participation in this trial.\n* Uncontrolled intercurrent illness including, but not limited to: Symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Pregnant or lactating females\n* Major surgery within 2 months before enrollment. Complete healing from major surgery must have occurred 1 month before enrollment. Complete healing from minor surgery (eg, simple excision, tooth extraction) must have occurred at least 7 days before enrollment. Subjects with clinically relevant complications from prior surgery are not eligible.\n\n  * Patients who undergo reoperation during their initial hospitalization will be censored at the time of reoperation.\n* Prisoner status",
    "miscellaneous_criteria": ""
}